FIELD: medicine, oncology.
SUBSTANCE: invention relates to using 2-chloroethylphosphonic acid sodium salt as an antitumor agent that displays enhanced effectiveness in treatment of different tumors, reduced toxicity and less adverse effects in comparison with many other antitumor agents.
EFFECT: valuable medicinal properties of agent.
4 ex
Authors
Dates
2007-11-10—Published
2002-09-18—Filed